French study checks if new combo works for mesothelioma in everyday practice
Knowledge-focused
Completed
This study looks back at 204 patients with untreated, inoperable malignant pleural mesothelioma who received a combination of two immunotherapy drugs, nivolumab and ipilimumab, through an early access program in France. Researchers will collect data from medical records to see ho…
Sponsor: Groupe Francais De Pneumo-Cancerologie • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC